Filing Details
- Accession Number:
- 0000911916-17-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-06 16:19:18
- Reporting Period:
- 2017-02-02
- Filing Date:
- 2017-02-06
- Accepted Time:
- 2017-02-06 16:19:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1136869 | Zimmer Biomet Holdings Inc. | ZBH | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 134151777 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239000 | C David Dvorak | C/O Zimmer, Inc. P. O. Box 708 Warsaw IN 46580 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-02 | 52,500 | $83.68 | 313,355 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-02 | 43,207 | $117.77 | 270,148 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-02-02 | 52,500 | $0.00 | 52,500 | $83.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-05 | No | 4 | M | Direct |
Footnotes
- Securities acquired pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- Includes 269 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017.
- Securities sold to cover option exercise cost, taxes and fess pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- Represents the sale of 43,207 shares in multiple transactions, ranging in price from $117.26 to $118.23 per share, resulting in a weighted average sale price of $117.7717. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.
Billionaire Hedge Funds
